Home
Conditions
Neoplasms, Glandular and Epithelial

Clinical trial condition

Neoplasms, Glandular and Epithelial

Explore clinical trials studying Neoplasms, Glandular and Epithelial. Study availability and eligibility vary by location and protocol.

17 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

Neoplasms, Glandular and Epithelial trial results

Recruiting

HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors

NCT03911388

Conditions: Astrocytoma, Astrocytoma, Cerebellar, Brain Diseases, +49 more
Locations: Children's of Alabama Birmingham, Alabama, United States

St. Louis Children's Hospital St Louis, Missouri, United States

MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

Efficacy and Safety of Multimodal Ablation Combined With PD-1 Monoclonal Antibody, Lenvatinib and TACE in the Treatment of Unresectable Primary Hepatocellular Carcinoma: A Single-Arm, Single-Center Clinical Study

NCT06794073

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +8 more
Locations: Zhongshan Hospital, Fudan University Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Pembrolizumab and Lenvatinib for Platinum- Sensitive Recurrent Ovarian Cancer

NCT04519151

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +25 more
Locations: Sheba Medical center Ramat Gan, Israel

View Trial Details

Not Yet Recruiting

Multitargeted Recombinant Ad5 PSA/MUC-1/Brachyury-Based Immunotherapy (TriAdeno) Vaccine With IL-15 Superagonist N-803 in Participants With Clinically Localized Prostate Cancer Undergoing Active Surveillance

NCT07574541

Conditions: Adenocarcinoma, Carcinoma, Genital Diseases, +12 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Completed

Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Parathyroidectomy

NCT05152927

Conditions: Adenoma, Calcium Metabolism Disorders, Endocrine Gland Neoplasms, +16 more
Locations: University of California, San Francisco San Francisco, California, United States

View Trial Details

Completed

Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors

NCT03037385

Conditions: Adenocarcinoma, Adenocarcinoma, Papillary, Bronchial Diseases, +55 more
Locations: Mayo Clinic Hospital Phoenix, Arizona, United States

UC Irvine Medical Center Orange, California, United States

University of Colorado Anschutz Medical Campus Aurora, Colorado, United States

Georgetown University Medical Center Washington D.C., District of Columbia, United States

View all 71 locations

View Trial Details

Completed

Evaluation of Ocoxin-Viusid® in Advanced or Metastatic Ovarian Epithelial Cancer

NCT03562897

Conditions: Adnexal Diseases, Carcinoma, Endocrine Gland Neoplasm, +23 more
Locations: National Institute of Oncology and Radiobiology (INOR) Havana, Cuba

View Trial Details

Completed

Cardiac Safety Study of Entinostat in Men and Women With Advanced Solid Tumors

NCT02897778

Conditions: Breast Diseases, Breast Neoplasms, Bronchial Diseases, +29 more
Locations: The START Center for Cancer Care San Antonio, Texas, United States

View Trial Details

Completed

A Study of Overall Survival in Participants With Unresectable Hepatocellular Carcinoma

NCT04008082

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +8 more
Locations: Eisai Trial Site #1 Osaka, Japan

Eisai Trial Site #2 Tokyo, Japan

View Trial Details

Completed

Continuation Study of Entinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumors

NCT02909452

Conditions: Breast Diseases, Bronchial Diseases, Bronchial Neoplasms, +28 more
Locations: The START Center for Cancer Care San Antonio, Texas, United States

View Trial Details

Neoplasms, Glandular and Epithelial

Neoplasms, Glandular and Epithelial trial results

Related conditions